$GLSI
Greenwich LifeSciences, Inc.

2021 Form 10-K Financial Statement

#000149315222007377 Filed on March 21, 2022

View on sec.gov

Income Statement

Concept 2021 2020
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.038M $810.0K
YoY Change 28.2% -1.22%
% of Gross Profit
Research & Development $3.560M $1.060M
YoY Change 235.8% -59.39%
% of Gross Profit
Depreciation & Amortization $3.610K $0.00
YoY Change
% of Gross Profit
Operating Expenses $4.598M $1.860M
YoY Change 147.2% -45.77%
Operating Profit -$4.598M
YoY Change
Interest Expense $27.37K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.571M -$1.860M
YoY Change 145.73% -45.77%
Income Tax
% Of Pretax Income
Net Earnings -$4.571M -$1.860M
YoY Change 145.73% -45.77%
Net Earnings / Revenue
Basic Earnings Per Share -$0.35
Diluted Earnings Per Share -$353.1K -$146.5K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.20M $28.66M
YoY Change -5.08% 286500.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $27.20M $28.66M
YoY Change -5.08% 286500.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $12.61K $20.00K
YoY Change -36.95% 0.0%
TOTAL ASSETS
Total Short-Term Assets $27.20M $28.66M
Total Long-Term Assets $12.61K $20.00K
Total Assets $27.22M $28.68M
YoY Change -5.1% 95500.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $220.9K $710.0K
YoY Change -68.89% -2.74%
Accrued Expenses $164.3K $60.00K
YoY Change 173.88% 500.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $280.0K
YoY Change -100.0% -56.25%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $385.2K $1.050M
YoY Change -63.32% -23.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $385.2K $1.050M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $385.2K $1.050M
YoY Change -63.32% -23.91%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.83M $27.63M
YoY Change
Total Liabilities & Shareholders Equity $27.22M $28.68M
YoY Change -5.1% 95500.0%

Cashflow Statement

Concept 2021 2020
OPERATING ACTIVITIES
Net Income -$4.571M -$1.860M
YoY Change 145.73% -45.77%
Depreciation, Depletion And Amortization $3.610K $0.00
YoY Change
Cash From Operating Activities -$4.292M -$1.150M
YoY Change 273.18% 296.55%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.835M 29.81M
YoY Change -90.49% 13450.0%
NET CHANGE
Cash From Operating Activities -4.292M -1.150M
Cash From Investing Activities
Cash From Financing Activities 2.835M 29.81M
Net Change In Cash -1.456M 28.66M
YoY Change -105.08% -41042.86%
FREE CASH FLOW
Cash From Operating Activities -$4.292M -$1.150M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
USD
CY2020 GLSI Additional Preferred Stock Issued Due To Antidilution
AdditionalPreferredStockIssuedDueToAntidilution
USD
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
USD
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
USD
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
USD
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
USD
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
USD
CY2021 us-gaap Stock Issued1
StockIssued1
USD
CY2020 us-gaap Stock Issued1
StockIssued1
USD
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
CY2021 GLSI Issuance Of Preferred Stock Due To Antidilution
IssuanceOfPreferredStockDueToAntidilution
USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD

Files In Submission

Name View Source Status
0001493152-22-007377-index-headers.html Edgar Link pending
0001493152-22-007377-index.html Edgar Link pending
0001493152-22-007377.txt Edgar Link pending
0001493152-22-007377-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
form10-k_003.jpg Edgar Link pending
form10-k_004.jpg Edgar Link pending
form10-k_005.jpg Edgar Link pending
form10-k_006.jpg Edgar Link pending
form10-k_007.jpg Edgar Link pending
form10-k_htm.xml Edgar Link completed
glsi-20211231.xsd Edgar Link pending
glsi-20211231_cal.xml Edgar Link unprocessable
glsi-20211231_def.xml Edgar Link unprocessable
glsi-20211231_lab.xml Edgar Link unprocessable
glsi-20211231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending